|
TOX4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.11700000005044E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.701400E-01 |
| Normal-vs-Stage2 |
1.771700E-04 |
| Normal-vs-Stage3 |
2.49759990467169E-10 |
| Normal-vs-Stage4 |
1.67460000310982E-08 |
| Stage1-vs-Stage2 |
2.097200E-03 |
| Stage1-vs-Stage3 |
2.0887999996333E-08 |
| Stage1-vs-Stage4 |
1.03340000001673E-07 |
| Stage2-vs-Stage3 |
3.196200E-01 |
| Stage2-vs-Stage4 |
1.952150E-01 |
| Stage3-vs-Stage4 |
5.836800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.28000000002115E-06 |
| Normal-vs-AfricanAmerican |
2.615900E-03 |
| Normal-vs-Asian |
4.683600E-01 |
| Caucasian-vs-AfricanAmerican |
6.368200E-01 |
| Caucasian-vs-Asian |
6.924200E-01 |
| AfricanAmerican-vs-Asian |
5.640000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.29719999969669E-07 |
| Normal-vs-Female |
2.781100E-03 |
| Male-vs-Female |
1.087170E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.856000E-02 |
| Normal-vs-Age(41-60Yrs) |
1.056250E-03 |
| Normal-vs-Age(61-80Yrs) |
6.02069999966481E-07 |
| Normal-vs-Age(81-100Yrs) |
1.152570E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.615600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.444800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.127200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.407560E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.074200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.465400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.494420E-02 |
| Normal-vs-Grade 2 |
7.584300E-02 |
| Normal-vs-Grade 3 |
4.15349999949299E-08 |
| Normal-vs-Grade 4 |
2.31169972053635E-10 |
| Grade 1-vs-Grade 2 |
1.055470E-03 |
| Grade 1-vs-Grade 3 |
1.62576999999109E-05 |
| Grade 1-vs-Grade 4 |
1.62810000037261E-07 |
| Grade 2-vs-Grade 3 |
7.64510000000884E-05 |
| Grade 2-vs-Grade 4 |
5.12999998036889E-09 |
| Grade 3-vs-Grade 4 |
5.835300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.558000E-01 |
| Normal-vs-ccB subtype |
2.32770469565935E-11 |
| ccA subtype-vs-ccB subtype |
3.7123637497416E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.350140E-04 |
| Normal-vs-N1 |
9.01445584844396E-12 |
| N0-vs-N1 |
7.65160000000265E-05 |
|
|
